PI-RADS version 2.1 demonstrated improved detection of clinically significant prostate cancer in the transition zone. For detecting clinically significant prostate cancer (csPCa), prostate imaging ...
AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.
MedPage Today on MSN
PSMA-PET Cuts Need for Biopsy in Suspected Prostate Cancer
But does it cost too much?
An artificial intelligence system slightly outperformed radiologists using PI-RADS at detecting clinically significant prostate cancer. A trained artificial intelligence (AI) system discriminated ...
Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...
Sequential flotufolastat-F18 PSMA-PET scans to enhance detection of prostate cancer in patients with early PSA recurrence following radical prostatectomy. Prevalence of treatment-acquired homozygous ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results